With earnings season now in full swing, the team takes a look at the latest results from Tesla and some of the most prominent ...

The MuliJector is aimed at processors looking to increase throughput, broaden their product range or update equipment to ...

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...

Johnson & ⁠Johnson is using artificial intelligence ⁠to slash by half the time it takes ​to generate new leads for developing ...